 Spandana Sphoorty Financial Ltd consolidated Q2FY26 loss at Rs. 249.13 crores
Spandana Sphoorty Financial Ltd consolidated Q2FY26 loss at Rs. 249.13 crores Steelcast Ltd posts higher PAT of Rs. 23.21 crores in Q2 FY26
Steelcast Ltd posts higher PAT of Rs. 23.21 crores in Q2 FY26 Schaeffler India Ltd Q3 CY2025 consolidated PAT up at Rs. 289.26 crores
Schaeffler India Ltd Q3 CY2025 consolidated PAT up at Rs. 289.26 crores Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore 
              The Nomination, Governance & Compensation committee of the Board of Directors of Dr Reddys Laboratories Ltd has allotted 6,105 equity shares of Rs. 5/- each of the Company, fully paid up, on January 05, 2017, to Employees on exercise of their Stock Options.
4,290 equity shares of Rs. 5/- each were allotted pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002 and 1,815 equity shares of Rs. 5/- each underlying 1,815 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.3168 as compared to the previous close of Rs. 3136.2. The total number of shares traded during the day was 16716 in over 2674 trades.
The stock hit an intraday high of Rs. 3203.95 and intraday low of 3144.15. The net turnover during the day was Rs. 53051274.